# Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-dk-22-506-limited-competition-for-the-continuation-of-the-apol1/  
Official notice: https://www.grants.gov/search-results-detail/343216

> National Institutes of Health offered grants to state and local governments. Applications closed on October 26, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-DK-22-506 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | October 26, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.307, 93.847 |

## Who can apply

- Independent school districts
- Public housing authorities/Indian housing authorities
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to renew the APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO) Clinical Centers (CCs), with a continued charge to determine laboratory parameters and clinical events in the kidney transplant recipients, according to the clinical and research efforts of the APOLLO Consortium. This FOA runs in parallel with a separate FOA that invites applications for the APOLLO SDRC (SDRC) (RFA-DK-22-507). The APOLLO Network study results are expected to enhance understanding of the associations of APOL1 genotype with renal transplant outcomes and provide evidence for optimizing allocation and management approaches to kidney donation in individuals of African Ancestry.

## Questions people ask

### Is RFA-DK-22-506 still open?

No. It closed on October 26, 2022.

### Who can apply for Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)?

Closed October 26, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-DK-22-506?

NIH RePORTER lists 13 projects funded under RFA-DK-22-506 in fiscal 2023 to 2026, at 13 institutions. The most were at Joslin Diabetes Center, Columbia University Health Sciences, Emory University.

### Who has won Minority Health and Health Disparities Research  grants before?

The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.